曼月乐和口服避孕药治疗卵巢子宫内膜异位症复发效果研究.docVIP

曼月乐和口服避孕药治疗卵巢子宫内膜异位症复发效果研究 　　【摘要】 目的：探讨曼月乐和口服避孕药在卵巢子宫内膜异位症复发治疗中的临床效果。方法：选取2014年1月-2016年1月笔者所在医院收治的复发卵巢子宫内膜异位症患者共67例，随机分为曼月乐组及口服避孕药组，比较两组患者治疗效果，卵巢巧克力囊肿体积、血清CA125水平，痛经、慢性盆腔痛的疼痛视觉模拟评分量表（VAS）评分。结果：曼月乐组总有效率为91.43%，显著高于口服避孕药组的75.00%，差异有统计学意义（P0.01）。与治疗后口服避孕药组比较，曼月乐组卵巢巧克力囊肿体积显著小，血清CA125水平显著低，痛经及慢性盆腔痛VAS评分显著低，差异有统计学意义（P0.01）。与此同时，曼月乐组及口服避孕药组治疗前后比较，卵巢巧克力囊肿体积显著缩小，血清CA125水平显著下降，痛经及慢性盆腔痛VAS评分显著下降，差异有统计学意义（P0.01）。结论：曼月乐在卵巢子宫内膜异位症复发治疗方面的应用价值明显优于口服避孕药。 　　【关键词】 曼月乐； 口服避孕药； 卵巢子宫内膜异位症； 复发 　　doi：10.14033/ki.cfmr.2017.17.008 文献标识码 B 文章编号 1674-6805（2017）17-0018-02 　　Study on the Effect of Mirena and Oral Contraceptives in the Treatment of Ovarian Endometriosis Recurrence/LIU Zhi-hong.//Chinese and Foreign Medical Research，2017，15（17）：18-19 　　【Abstract】 Objective：To investigate the clinical effect of Mirena and oral Contraceptives in the treatment of ovarian endometriosis recurrence.Method：From January 2014 to January 2016，67 cases of ovarian endometriosis recurrence patients in our hospital were selected，they were randomly divided into the Mirena group and the oral Contraceptives group，the treatment effect，ovarian ectopic cyst volume，serum CA125 level，pain visual analogue scale dysmenorrhea，chronic pelvic pain（VAS score） in the two groups were compared.Result：The total effective rate in the Mirena group was 91.43%，it was significantly higher than 75.00% of the oral Contraceptive group，the difference was statistically significant（P0.01）.Compared with the oral Contraceptive group after treatment，the Mirena group ovarian chocolate cyst volume was significantly reduced，the serum level of CA125 decreased significantly，dysmenorrhea and chronic pelvic pain VAS score decreased significantly，the differences were statistically significant（P0.01）.At the same time，the Mirena group and the oral contraceptives group before and after treatment comparison，ovarian chocolate cyst volume was significantly reduced，the serum level of CA125 decreased significantly，dysmenorrhea and chronic pelvic pain V